{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05688436",
            "orgStudyIdInfo": {
                "id": "272MS402"
            },
            "organization": {
                "fullName": "Biogen",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate",
            "officialTitle": "Pregnancy Outcomes in Women Exposed to Diroximel Fumarate",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-assess-pregnancy-outcomes-in-women-exposed-to-diroximel-fumarate"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2031-01-17",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2031-01-17",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-09",
            "studyFirstSubmitQcDate": "2023-01-09",
            "studyFirstPostDateStruct": {
                "date": "2023-01-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Biogen",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of the study is to estimate the prevalence of major congenital malformations (MCMs) and compare the prevalence between the diroximel fumarate (DRF) and comparator groups. The secondary objectives of the study are to estimate the incidence of spontaneous abortion (SA) and compare the incidence between the DRF and comparator groups; to estimate the incidence of preterm birth and compare the incidence between the DRF and comparator groups; to estimate the incidence of stillbirth and compare the incidence between the DRF and comparator groups and to estimate the prevalence of small for gestational age (SGA) and compare the prevalence between the DRF and comparator groups."
        },
        "conditionsModule": {
            "conditions": [
                "Multiple Sclerosis"
            ],
            "keywords": [
                "Pregnancy",
                "Relapsing forms of Multiple Sclerosis (MS)"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "1 Year",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 1178,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Diroximel Fumarate (DRF)",
                    "description": "Pregnant women with MS who were exposed to DRF.",
                    "interventionNames": [
                        "Drug: Diroximel Fumarate"
                    ]
                },
                {
                    "label": "Non-DRF",
                    "description": "Pregnant women with MS who were exposed to disease-modifying therapies (DMTs) other than DRF.",
                    "interventionNames": [
                        "Biological: Alemtuzumab",
                        "Drug: Fingolimod",
                        "Drug: Glatiramer acetate",
                        "Biological: Interferon beta",
                        "Biological: Natalizumab",
                        "Biological: Ocrelizumab",
                        "Biological: Ofatumumab",
                        "Drug: Ozanimod",
                        "Biological: Peginterferon beta-1a",
                        "Drug: Ponesimod",
                        "Drug: Siponimod"
                    ]
                },
                {
                    "label": "Non-DMT",
                    "description": "Pregnant women with MS who were not exposed to DMTs."
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Diroximel Fumarate",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Diroximel Fumarate (DRF)"
                    ],
                    "otherNames": [
                        "VUMERITY",
                        "BIIB098"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Alemtuzumab",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fingolimod",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Glatiramer acetate",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Interferon beta",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Natalizumab",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ],
                    "otherNames": [
                        "Tysabri",
                        "BG00002"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Ocrelizumab",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Ofatumumab",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ozanimod",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Peginterferon beta-1a",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ponesimod",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Siponimod",
                    "description": "Administered as specified in the treatment arm.",
                    "armGroupLabels": [
                        "Non-DRF"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Major Congenital Malformations (MCMs)",
                    "description": "MCMs includes abnormalities in structural development that are medically or cosmetically significant are present at birth and persist in postnatal life unless or until repaired.",
                    "timeFrame": "Up to 52 weeks postdelivery"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of Spontaneous Abortions",
                    "description": "Spontaneous abortion is defined as the loss of a fetus due to natural causes before 20th week of gestation.",
                    "timeFrame": "Before 20 weeks of gestation"
                },
                {
                    "measure": "Number of Preterm Births",
                    "description": "Preterm birth is defined as a live birth at or before the 37th week of gestation.",
                    "timeFrame": "At or before the 37 weeks of gestation"
                },
                {
                    "measure": "Number of Stillbirths",
                    "description": "Stillbirth is defined as the loss of pregnancy at or after the 20th week of gestation.",
                    "timeFrame": "At or after the 20 weeks of gestation"
                },
                {
                    "measure": "Number of Small for Gestational Age (SGA)",
                    "description": "SGA is defined as birthweight below the 10th percentile for gestational age.",
                    "timeFrame": "Up to 52 weeks postdelivery"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Last menstrual period (LMP) between 29 October 2019 and 31 July 2030.\n* Continuous medical and pharmacy coverage for a minimum of 6 months prior to and including the estimated LMP.\n* Presence of MS.\n\nKey Exclusion Criteria:\n\n- Pregnancies will be excluded from this study if they are exposed to any known teratogens from the beginning of baseline through the end of the relevant exposure window.\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "minimumAge": "18 Years",
            "maximumAge": "49 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "The participants included in this study will be drawn from the population of adult women with MS who become pregnant between 29 October 2019 and 31 July 2030.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "US Biogen Clinical Trial Center",
                    "role": "CONTACT",
                    "phone": "866-633-4636",
                    "email": "clinicaltrials@biogen.com"
                },
                {
                    "name": "Global Biogen Clinical Trial Center",
                    "role": "CONTACT",
                    "email": "clinicaltrials@biogen.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Biogen",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "OptumInsight",
                    "status": "RECRUITING",
                    "city": "Eden Prairie",
                    "state": "Minnesota",
                    "zip": "55344-2503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Optum Research Database",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.85469,
                        "lon": -93.47079
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "In accordance with Biogen's Clinical Trial Transparency and Data Sharing Policy on https://www.biogentrialtransparency.com/",
            "url": "https://vivli.org/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009103",
                    "term": "Multiple Sclerosis"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000020278",
                    "term": "Demyelinating Autoimmune Diseases, CNS"
                },
                {
                    "id": "D000020274",
                    "term": "Autoimmune Diseases of the Nervous System"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12060",
                    "name": "Multiple Sclerosis",
                    "asFound": "Multiple Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22098",
                    "name": "Demyelinating Autoimmune Diseases, CNS",
                    "relevance": "LOW"
                },
                {
                    "id": "M22094",
                    "name": "Autoimmune Diseases of the Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007372",
                    "term": "Interferons"
                },
                {
                    "id": "D000016899",
                    "term": "Interferon-beta"
                },
                {
                    "id": "D000074323",
                    "term": "Alemtuzumab"
                },
                {
                    "id": "C000527517",
                    "term": "Ofatumumab"
                },
                {
                    "id": "D000068717",
                    "term": "Glatiramer Acetate"
                },
                {
                    "id": "C000533411",
                    "term": "Ocrelizumab"
                },
                {
                    "id": "D000069442",
                    "term": "Natalizumab"
                },
                {
                    "id": "D000068876",
                    "term": "Fingolimod Hydrochloride"
                },
                {
                    "id": "C000021759",
                    "term": "(T,G)-A-L"
                },
                {
                    "id": "C000607776",
                    "term": "Ozanimod"
                },
                {
                    "id": "C000550169",
                    "term": "Ponesimod"
                },
                {
                    "id": "C000578989",
                    "term": "Siponimod"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000081243",
                    "term": "Sphingosine 1 Phosphate Receptor Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000000276",
                    "term": "Adjuvants, Immunologic"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M216548",
                    "name": "Ozanimod",
                    "asFound": "Movement Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10407",
                    "name": "Interferons",
                    "asFound": "Food",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19244",
                    "name": "Interferon-beta",
                    "asFound": "Cervical Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M288908",
                    "name": "Ocrelizumab",
                    "asFound": "Susceptibility",
                    "relevance": "HIGH"
                },
                {
                    "id": "M347498",
                    "name": "Ofatumumab",
                    "asFound": "Abnormal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M323",
                    "name": "Fingolimod Hydrochloride",
                    "asFound": "Restorative",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1347",
                    "name": "Alemtuzumab",
                    "asFound": "Transcranial Direct Current Stimulation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M297",
                    "name": "Glatiramer Acetate",
                    "asFound": "ASC",
                    "relevance": "HIGH"
                },
                {
                    "id": "M147897",
                    "name": "(T,G)-A-L",
                    "asFound": "ASC",
                    "relevance": "HIGH"
                },
                {
                    "id": "M411",
                    "name": "Natalizumab",
                    "asFound": "BCMA",
                    "relevance": "HIGH"
                },
                {
                    "id": "M271031",
                    "name": "Ponesimod",
                    "asFound": "Concentrate for solution for infusion",
                    "relevance": "HIGH"
                },
                {
                    "id": "M271068",
                    "name": "Siponimod",
                    "asFound": "Arithmetic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3628",
                    "name": "Adjuvants, Immunologic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                }
            ]
        }
    },
    "hasResults": false
}